Chest
Volume 113, Issue 1, January 1998, Pages 25-27
Journal home page for Chest

Clinical Investigations
Tuberculin and Anergy Skin Testing of Patients Receiving Long-term Hemodialysis

https://doi.org/10.1378/chest.113.1.25Get rights and content
Under a Creative Commons license
open archive

Study objectives

Immunocompromised patients with chronic renal failure requiring hemodialysis (HD) are at increased risk of developing tuberculosis (TB). Routine TB screening of this population is recommended. This study examined the frequency of TB reactions and anergy in HD patients in a community with a high prevalence of TB.

Design

Outpatients in a hospital-based HD center were screened with tuberculin, Candida, and mumps antigen.

Results

Forty percent of patients were anergic and 19% were tuberculin reactors. No demographic factors correlated with either test results.

Conclusions

There was a high rate of TB infection and anergy in this HD center. Despite the high rate of anergy, tuberculin testing remains a useful test in this population. Anergic patients require further clinical evaluation for TB. Other HD programs should tuberculin and anergy test their patients to determine prevalence in their populations.

Key words

anergy
chronic renal failure
hemodialysis
tuberculin testing
tuberculosis

Abbrevations

BCG
=bacille Calmette-Guérin (vaccine)
HD
=hemodialysis
PPD
=purified protein derivative
TB
=tuberculosis

Cited by (0)